Clinical Trial Update: A Hepatitis B Vaccine Challenge Study After Previous Vaxelis® Vaccination (V419-013) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating a Hepatitis B vaccine challenge after prior Vaxelis vaccination has completed; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Vaxelis (DTaP5-HBV-IPV-Hib)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis B | Phase 3 | Status: COMPLETED | Results posted: 2021-09-05